Bosnia and Herzegovina vs Netherlands: The number of people with susceptibility test result for rifampicin
Bosnia and Herzegovina
255
in 2021
Netherlands
270
in 2021
Bosnia and Herzegovina rank
89th
Netherlands rank
88th
The number of people with susceptibility test result for rifampicin over time
- Bosnia and Herzegovina
- Netherlands
How they compare
Netherlands currently reports 270 against 255 in Bosnia and Herzegovina, a difference of 15.
That makes Netherlands's figure about 1.1 times Bosnia and Herzegovina's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 89th and Netherlands ranks 88th of 155 countries.
Across the 2 decades both report, Bosnia and Herzegovina averaged higher in 1 and Netherlands in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 362 | 322.33 | 39.67 | Bosnia and Herzegovina |
| 2020s | 231.5 | 257 | 25.5 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bosnia and Herzegovina or Netherlands?
- Netherlands, at 270 against 255 in Bosnia and Herzegovina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bosnia and Herzegovina and Netherlands?
- 15, with Netherlands ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Netherlands?
- 5 years are reported by both, from 2017 to 2021.
- How do Bosnia and Herzegovina and Netherlands rank globally for the number of people with susceptibility test result for rifampicin?
- Bosnia and Herzegovina ranks 89th and Netherlands ranks 88th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.